Lexicon Pharmaceuticals (LXRX) Treasury Shares (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Treasury Shares data on file, last reported at $2.8 million in Q1 2026.

• Quarterly Treasury Shares fell 45.19% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 45.19% YoY) and the FY2025 annual result came in at $5.2 million, up 12.39% from the prior year.
• Treasury Shares declined to $2.8 million in Q1 2026 per LXRX's latest filing, from $5.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $16.5 million in Q1 2025 and bottomed at $488000.0 in Q2 2022.
• The 5-year median for Treasury Shares is $1.5 million (2024), against an average of $5.2 million.
• The widest annual swing landed in 2022, when Treasury Shares plunged 72.59%; it then jumped 59.97% in 2024.
• Tracing LXRX's Treasury Shares over 5 years: stood at $2.1 million in 2022, then soared by 39.98% to $2.9 million in 2023, then jumped by 59.97% to $4.6 million in 2024, then grew by 12.39% to $5.2 million in 2025, then sank by 45.19% to $2.8 million in 2026.
• Per Business Quant, the three latest LXRX Treasury Shares figures stand at $2.8 million (Q1 2026), $5.2 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison